Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Transcriptome sequencing (RNA-Seq) reveals non-coding pseudogene CDC27P9 role in cervical cancer.
Fenwick Antony Edwin Rodrigues1, Deena Krishnan1, Hussein Hameed Abbas1
1Molecular Genetics and Cancer Biology Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Tamil Nadu, 641046, India.
Pseudogene CDC27P9 is upregulated in cervical cancer, promoting tumor progression by affecting cell cycle and apoptosis. Silencing CDC27P9 inhibits cancer growth and downregulates HPV 18, suggesting it as a potential therapeutic target.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Pseudogenes, once considered non-functional genomic remnants, are increasingly recognized for their roles in cellular processes.
- The specific function of pseudogene CDC27P9 in cervical cancer has remained largely uninvestigated.
- Understanding novel genetic players in cervical cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the functional role of the pseudogene CDC27P9 in cervical cancer.
- To explore the molecular mechanisms by which CDC27P9 influences cancer progression, cell cycle regulation, and apoptosis.
- To assess the potential of CDC27P9 as a therapeutic target in cervical cancer.
Main Methods:
- Whole RNA-transcriptome profiling of blood samples from cervical cancer patients and healthy controls.
- RT-PCR validation of CDC27P9 expression.
- In silico prediction and refinement of the CDC27P9-encoded protein structure.
- Molecular docking and MD simulations to analyze interactions with CDC27 and CDC20.
- siRNA-mediated silencing of CDC27P9 in HeLa cells to study effects on the Anaphase Promoting Complex/Cyclosome (APC/C) pathway, cell cycle, apoptosis, and HPV 18 expression.
- Flow cytometry, Laser Scanning Confocal Microscopy, and microplate reader assays for functional assessments.
Main Results:
- Transcriptome sequencing revealed significant upregulation of CDC27P9 (log2FC=10.68) in cervical cancer patients, validated by RT-PCR.
- The predicted CDC27P9 protein showed high structural reliability and strong interactions with CDC27 and CDC20.
- Silencing CDC27P9 led to downregulation of APC/C genes, reduced BCL2 (anti-apoptotic), increased BAX (pro-apoptotic), induced S-phase cell cycle arrest, apoptosis, and mitochondrial membrane potential loss.
- CDC27P9 silencing also resulted in chromatin condensation, cell death, growth inhibition, and importantly, downregulation of HPV 18 in HeLa cells.
Conclusions:
- This study identifies pseudogene CDC27P9 as a functional entity with active transcripts and protein-coding potential in cervical cancer.
- CDC27P9 contributes to cervical cancer progression by modulating APC/C-mediated cell-cycle pathways and inhibiting apoptosis, thereby promoting cancer cell survival.
- CDC27P9's role in HPV18-associated pathways and its impact on cancer progression highlight its potential as a novel therapeutic target for cervical cancer.
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
lncRNA - Long Non-coding RNAs
piRNA - Piwi-interacting RNAs
Cis-regulatory Sequences
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

